-transparent.png){kind=logo}
A new series of thiazole-containing triazole antifungals was synthesized and evaluated for antifungal activity against a variety of clinically isolated pathogenic fungi in vitro and against systemic candidosis in vivo. Among these compounds, (+/-)-1-(2,4-difluorophenyl)-1-[4-(2,4-difluorophenyl) thiazol-2-yl]-2-(1H-1,2,4-triazol-1-yl)ethanol (ER24161) showed the most potent and well-balanced in vitro activities and excellent in vivo efficacy. We also achieved an enantioselective synthesis of the more potent enantiomer of ER-24161.
Related Publications
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
October 2013,
Archives of pharmacal research,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
July 2014,
Molecules (Basel, Switzerland),
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
December 2004,
Yao xue xue bao = Acta pharmaceutica Sinica,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
July 2014,
European journal of medicinal chemistry,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
October 2011,
Archives of pharmacal research,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
February 2013,
Chemistry Central journal,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
February 2009,
Bioorganic & medicinal chemistry letters,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
February 2015,
Molecular diversity,
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
June 2016,
Molecules (Basel, Switzerland),
A Tsuruoka, and
Y Kaku, and
H Kakinuma, and
I Tsukada, and
M Yanagisawa, and
T Naito
January 2015,
Journal of advanced pharmaceutical technology & research,
